(19)
(11) EP 1 849 466 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
07.11.2012 Bulletin 2012/45

(45) Mention of the grant of the patent:
18.01.2012 Bulletin 2012/03

(21) Application number: 07251707.1

(22) Date of filing: 24.04.2007
(51) International Patent Classification (IPC): 
A61K 31/195(2006.01)
A61K 31/401(2006.01)
A61K 9/08(2006.01)
 A61K 31/198(2006.01)
A61K 31/405(2006.01)

(54)

Infusion fluid for treating anemia in dialysis patients

Infusionsflüssigkeit zur Behandlung der Anämie bei Dialysepatienten

Liquide d'infusion pour le traitement de l'anémie chez les patients sous dialyse

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 24.04.2006 JP 2006119694
27.04.2006 JP 2006124235
21.06.2006 JP 2006171886

(43) Date of publication of application:
31.10.2007 Bulletin 2007/44

(73) Proprietor: AJINOMOTO CO., INC.
Chuo-ku Tokyo 104-8315 (JP)

(72) Inventor:
  • Sugiyama, Takayuki
    Tokyo 104-8315 (JP)

(74) Representative: Nicholls, Kathryn Margaret et al
Mewburn Ellis LLP 33 Gutter Lane
London EC2V 8AS
London EC2V 8AS (GB)


(56) References cited: : 
US-A1- 2002 144 946
US-B1- 6 830 692
 US-A1- 2005 148 647
   
  • NAVARRO JUAN F ET AL: "Amino acid losses during hemodialysis with polyacrylonitrile membranes: Effect of intradialytic amino acid supplementation on plasma amino acid concentrations and nutritional variables in nondiabetic patients" AMERICAN JOURNAL OF CLINICAL NUTRITION, vol. 71, no. 3, March 2000 (2000-03), pages 765-773, XP002445740 ISSN: 0002-9165
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).